$KEP

KEP Q2 2026 Earnings Call Transcript

Korea Electric Power (KEP/KEPCO) reported 1H 2026 consolidated revenue of KRW 46,317.3 billion (+0.3% YoY) and operating income of KRW 4,912.7 billion. Power sales revenue fell 0.4% on weaker industrial demand, while other revenue rose 16.7% on overseas performance. Fuel costs rose 8.8% and nuclear maintenance constrained capacity factors; SMP rose to 151 in August.

Original reporting
Published Aug 14, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 6:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
KEP Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$KEPNeutralMed
01

Why it matters

Management emphasized weak first-half nuclear capacity factors from prolonged preventive maintenance, higher fuel costs (LNG and coal), and a funding challenge from a statutory bond issuance cap reduction by end-2027. They also noted SMP has risen in August, and a regional pricing differentiation system is expected to be finalized by end-2026.

02

Market read

Traders can update near-term earnings and liquidity expectations based on quantified cost drivers, SMP trajectory, and the stated path to meet the 2027 bond issuance cap via operating profit and potential tariff adjustments.

03

What to watch

Tariff hikes and the end-2026 regional pricing system are key swing factors, but the article does not quantify tariff magnitude or timing certainty, leaving execution risk.

Relevance 7/10Novelty 6/10Timing: post-call, ahead of tariff public hearings and end-2026 regional pricing system rollout

Background

Korea Electric Power (KEP) discussed preliminary IFRS 1H 2026 results and operational drivers, including nuclear maintenance and fuel-cost pass-through timing.

Company-level read

Ticker impact

$KEPNeutralMedium confidence
Context

KEP reported 1H 2026 operating income of KRW 4,912.7B and flagged weak nuclear capacity factors from prolonged preventive maintenance.

Expected impact

Near-term volatility risk around SMP and tariff-hearing timelines; direction depends on whether August SMP strength offsets cost and maintenance headwinds.

Evidence & confidence

The article provides multiple quantified operating drivers (revenue, fuel costs, SMP rising to 151 in August) plus explicit risks (maintenance, fuel cost lag, bond cap challenge) that can reprice near-term earnings power and funding expectations.

Market effects

Signals ongoing thermal generation reliance (coal vs LNG) driven by fuel price dynamics and maintenance scheduling, relevant for power utilities and fuel-linked cost models.

Korea electricity pricing and tariff policy expectations may influence broader KR power sector sentiment.

Fuel-cost references (LNG, coal) tie into global commodity price sensitivity for power producers, though the article is primarily company-specific.

Counterpoint

August SMP rising to 151 may partially offset first-half weakness, so the market may focus more on pricing power and less on maintenance-driven capacity factor declines.

Key entities

  • Korea Electric Power

    Subject of the earnings call transcript, reporting 1H 2026 operating income and outlining risks and funding/tariff plans.

  • KHNP

    Subsidiary referenced for nuclear capacity factor and maintenance-related impacts.

Related articles

$LCTCMed

Lifeloc Technologies, Inc (LCTC): Results of Operations and Financial Condition

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports Second Quarter 2026 Results WHEAT RIDGE, Colo., August 13, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announc

$HCWBMed

HCW Biologics Inc. (HCWB): Results of Operations and Financial Condition

HCW Biologics Inc. (HCWB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 EXHIBIT 99.1 HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results Miramar, FL – August 14, 2026 – HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmac

$RDIMed

READING INTERNATIONAL INC (RDI): Results of Operations and Financial Condition

READING INTERNATIONAL INC (RDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rdi-20260814xex99_1.htm EX-99.1 Exhibit 99.1 - 2026 Q2 Earnings Release  For more information, contact: Gilbert Avanes – EVP, CFO, and Treasurer (213) 235-22 40 Reading International Reports Second Quarter 2026 Results Earnings Call Webcast to Discuss Second Quarter Fi

$EMMAMed

Emmaus Life Sciences, Inc. (EMMA): Results of Operations and Financial Condition

Emmaus Life Sciences, Inc. (EMMA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030209901ex99-1.htm PRESS RELEASE DATED AUGUST 14, 2026 Exhibit 99.1 Emmaus Life Sciences Reports Quarterly Financial Results Torrance CA, August 14, 2026 - Emmaus Life Sciences, Inc. (OTCQB: EMMA) , a commercial-stage biopharmaceutical company and leader in the treat

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (LIF) shares fell about 18% for the week after the company reported Q2 earnings. According to Life360, Q2 revenue rose 38%, MAUs grew 16% to over 100 million, and adjusted EBITDA increased 53%. The stock dropped despite beating analyst expectations because management did not raise full-year guidance.

$HAWKMed

Why HawkEye 360 Stock Crashed Friday

HawkEye 360 (HAWK) shares fell about 7% after the company reported Q2 results. Analysts expected a GAAP loss of $0.12 per share on $45.5M revenue; HawkEye reported a $0.07 loss and $49.8M revenue. Sales rose 87% YoY, with international revenue over 42%. Management forecast FY sales of $215M to $220M.